The impact of post-market regulatory safety advisories on patients, prescribers, and the healthcare system

1Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This is a protocol for a Cochrane Review (Intervention). The objectives are as follows:. The main objective is to assess the impact of post-market regulatory safety advisories on safety outcomes in patients. Other objectives are to assess the impact of safety advisories on drug utilisation, health services utilisation (e.g. hospitalisations, clinical monitoring, or diagnostic testing), patient-health professional interaction (e.g. informed consent), and healthcare professional or patient/carer knowledge, attitudes, beliefs, and intended behaviours. Additional objectives, if feasible, are to identify attributes of prescription drug safety advisories that enhance or jeopardise their effectiveness.

Cite

CITATION STYLE

APA

Puil, L., Lexchin, J., Bero, L., Mangin, D., Hallgreen, C. E., Wong, G. W. K., & Mintzes, B. (2019). The impact of post-market regulatory safety advisories on patients, prescribers, and the healthcare system. Cochrane Database of Systematic Reviews, 2019(12). https://doi.org/10.1002/14651858.CD013510

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free